As of Jun 27
| +0.21 / +5.30%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +115.83% increase from the last price of 4.17.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.